You are here: Industry Insights > Coriolis Pharma

News List

Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions B3C newswire
November 06, 2023
Coriolis Pharma, a global service provider and a world leader in the formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines, today announced an investment from funds managed by KKR.
Coriolis Pharma Strengthens its Presence in North America by Appointing Formulation Expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board PharmaSources
February 01, 2023
Prof. Dr. Reza Nejadnik's research at the University of Iowa, College of Pharmacy, is focused on protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces.
Coriolis Pharma and U-Medico Announce a Strategic Alliance b3cnewswire
March 17, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation...
Coriolis Pharma Opens New ATMP Formulation Development Facilities B3Cnewswire
February 07, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines...
Coriolis Pharma Expands its ATMP Development Facilities b3cnewswire
June 22, 2021
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, today announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2 / S2)